Reklama produktów leczniczych a ochrona interesu konsumenta
This article addresses the issue of advertising of medicinal products from the perspective of protecting the consumer’s interest. As the research problem of the article was chosen to reconstruct the normative pattern of indirect consumer protection against incompatible with the provisions of PrFarm...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wydawnictwo Naukowe Uniwersytetu Szczecińskiego
2023-01-01
|
| Series: | Acta Iuris Stetinensis |
| Subjects: | |
| Online Access: | https://wnus.usz.edu.pl/ais/pl/issue/1353/article/20723/ |
| _version_ | 1797257354711924736 |
|---|---|
| author | Weronika Woźna-Burdziak |
| author_facet | Weronika Woźna-Burdziak |
| author_sort | Weronika Woźna-Burdziak |
| collection | DOAJ |
| description | This article addresses the issue of advertising of medicinal products from the perspective of protecting the consumer’s interest. As the research problem of the article was chosen to reconstruct the normative pattern of indirect consumer protection against incompatible with the provisions of PrFarm advertising of medicinal products directed to the public. The paper uses the dogmatic-legal method. In order to be able to solve the research problem posed, it was necessary to analyze the current state of the law with reference to doctrine and case law. The chosen research method made it possible to answer the research questions posed in the study concerning, among other things, whether the current form of supervision of advertising of medicinal products (or more precisely: supervision of the legality of advertising of medicinal products) is sufficient, and whether the patient/consumer is effectively protected from inconsistent PrFarm advertising of medicinal products directed to the public. As a result of the study, it was concluded that the current regulations on supervision of advertising of medicinal products to the public are not sufficiently effective, as they do not sufficiently protect the interests of the consumer. The above made it possible to propose changes to the current regulations in the form of introducing ex ante control of advertising of medicinal products to the public. |
| first_indexed | 2024-04-24T22:36:19Z |
| format | Article |
| id | doaj.art-eacf8ef4f5f64943848f54914c87e5c8 |
| institution | Directory Open Access Journal |
| issn | 2083-4373 |
| language | English |
| last_indexed | 2024-04-24T22:36:19Z |
| publishDate | 2023-01-01 |
| publisher | Wydawnictwo Naukowe Uniwersytetu Szczecińskiego |
| record_format | Article |
| series | Acta Iuris Stetinensis |
| spelling | doaj.art-eacf8ef4f5f64943848f54914c87e5c82024-03-19T10:29:25ZengWydawnictwo Naukowe Uniwersytetu SzczecińskiegoActa Iuris Stetinensis2083-43732023-01-014610.18276/ais.2023.46-10Reklama produktów leczniczych a ochrona interesu konsumentaWeronika Woźna-Burdziak0Uniwersytet SzczecińskiThis article addresses the issue of advertising of medicinal products from the perspective of protecting the consumer’s interest. As the research problem of the article was chosen to reconstruct the normative pattern of indirect consumer protection against incompatible with the provisions of PrFarm advertising of medicinal products directed to the public. The paper uses the dogmatic-legal method. In order to be able to solve the research problem posed, it was necessary to analyze the current state of the law with reference to doctrine and case law. The chosen research method made it possible to answer the research questions posed in the study concerning, among other things, whether the current form of supervision of advertising of medicinal products (or more precisely: supervision of the legality of advertising of medicinal products) is sufficient, and whether the patient/consumer is effectively protected from inconsistent PrFarm advertising of medicinal products directed to the public. As a result of the study, it was concluded that the current regulations on supervision of advertising of medicinal products to the public are not sufficiently effective, as they do not sufficiently protect the interests of the consumer. The above made it possible to propose changes to the current regulations in the form of introducing ex ante control of advertising of medicinal products to the public.https://wnus.usz.edu.pl/ais/pl/issue/1353/article/20723/advertisingmedicinal productsconsumer |
| spellingShingle | Weronika Woźna-Burdziak Reklama produktów leczniczych a ochrona interesu konsumenta Acta Iuris Stetinensis advertising medicinal products consumer |
| title | Reklama produktów leczniczych a ochrona interesu konsumenta |
| title_full | Reklama produktów leczniczych a ochrona interesu konsumenta |
| title_fullStr | Reklama produktów leczniczych a ochrona interesu konsumenta |
| title_full_unstemmed | Reklama produktów leczniczych a ochrona interesu konsumenta |
| title_short | Reklama produktów leczniczych a ochrona interesu konsumenta |
| title_sort | reklama produktow leczniczych a ochrona interesu konsumenta |
| topic | advertising medicinal products consumer |
| url | https://wnus.usz.edu.pl/ais/pl/issue/1353/article/20723/ |
| work_keys_str_mv | AT weronikawoznaburdziak reklamaproduktowleczniczychaochronainteresukonsumenta |